Literature DB >> 8770937

Regulation and localization of cellular retinol-binding protein, retinol-binding protein, cellular retinoic acid-binding protein (CRABP), and CRABP II in the uterus of the pseudopregnant rat.

R A Bucco1, W L Zheng, S A Wardlaw, J T Davis, E Sierra-Rivera, K G Osteen, M H Melner, B P Kakkad, D E Ong.   

Abstract

Three members of the superfamily of small intracellular carrier proteins for lipophilic compounds are cellular retinol-binding protein (CRBP), cellular retinoic acid-binding protein (CRABP), and cellular retinoic acid-binding protein II (CRABP II). Retinol-binding protein (RBP) is a secreted protein that binds and solubilizes vitamin A for transport. Here we report the coordinate regulation of RBP, CRBP, retinol, and CRABP II in the uterus of the pseudopregnant rat. In the proliferative stage of the uterus, which was induced by PMSG, the messenger RNA (mRNA) and protein levels of RBP and CRBP as well as retinol levels significantly decreased. This pattern of regulation was duplicated by estrogen treatment of prepubertal rats. In addition, CRBP and RBP were found to be colocalized to the stromal cells of the rat uterus by immunohistochemistry and [35S]methionine-labeled affinity chromatography, respectively, and were not detected in other cell populations. CRABP II mRNA and protein expression were up-regulated in the proliferative phase of the uterus brought about by PMSG injection or, alternatively, by estrogen treatment of prepubertal rats. CRABP II was localized to the surface epithelium, but was not seen elsewhere, including glandular epithelium. Immunolocalization of CRABP showed staining of the smooth muscle and stromal cells of the uterus. The appearance of CRABP in the stroma of the uterus also correlated with PMSG injection as well as estrogen treatment. Although estrogen induced the appearance of both binding proteins, CRABP mRNA levels peaked between 4-24 h postestrogen treatment, whereas CRABP II mRNA levels continued to rise 48 h postestrogen treatment. These data demonstrate an important role for vitamin A and retinoid-binding proteins in rat uterine physiology.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770937     DOI: 10.1210/endo.137.7.8770937

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Altered retinoid uptake and action contributes to cell survival in endometriosis.

Authors:  Mary Ellen Pavone; Scott Reierstad; Hui Sun; Magdy Milad; Serdar E Bulun; You-Hong Cheng
Journal:  J Clin Endocrinol Metab       Date:  2010-08-11       Impact factor: 5.958

2.  Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal.

Authors:  Robert N O'Brien; Zhouxin Shen; Kiyoshi Tachikawa; Pei Angel Lee; Steven P Briggs
Journal:  Mol Cell Proteomics       Date:  2010-05-31       Impact factor: 5.911

3.  Localization of retinaldehyde dehydrogenases and retinoid binding proteins to sustentacular cells, glia, Bowman's gland cells, and stroma: potential sites of retinoic acid synthesis in the postnatal rat olfactory organ.

Authors:  Mary Ann Asson-Batres; W Bradford Smith
Journal:  J Comp Neurol       Date:  2006-05-10       Impact factor: 3.215

4.  LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.

Authors:  Michelle A Lane; Juliana Xu; Elana W Wilen; Renia Sylvester; Fadila Derguini; Lorraine J Gudas
Journal:  Mol Cell Endocrinol       Date:  2007-10-06       Impact factor: 4.102

5.  Profile of estrogen-responsive genes in an estrogen-specific mammary gland outgrowth model.

Authors:  Bonnie J Deroo; Sylvia C Hewitt; Jennifer B Collins; Sherry F Grissom; Katherine J Hamilton; Kenneth S Korach
Journal:  Mol Reprod Dev       Date:  2009-08       Impact factor: 2.609

Review 6.  Enzymology of retinoic acid biosynthesis and degradation.

Authors:  Natalia Y Kedishvili
Journal:  J Lipid Res       Date:  2013-04-29       Impact factor: 5.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.